Remdesivir is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. As of 2020, remdesivir is being tested as a specific treatment for COVID-19, and has been authorized for emergency use in the U.S. and approved for use in Japan for people with severe symptoms. Reference standards of Remdesivir API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 2-Ethylbutyl ((4-nitrophenoxy)(phenoxy)phosphoryl)-L-alaninate (BSC) [catalogue_number] => PA BSC 10818870 [category_ids] => ,169, [chemical_name] => [weight] => 450.43 [form] => C21H27N2O7P [cas] => 1439900-56-7 [pslug] => 1439900-56-7-2-ethylbutyl-4-nitrophenoxy-phenoxy-phosphoryl-l-alaninate-bsc-pabsc10818870 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 10818870
CAS :
Molecular Formula : C21H27N2O7P
Molecular Weight : 450.43
stdClass Object ( [pname] => Pyrrolo[2,1-f][1,2,4]triazin-4-amine (BSC) [catalogue_number] => PA BSC 10818936 [category_ids] => ,169, [chemical_name] => [weight] => 134.14 [form] => C6H6N4 [cas] => 159326-68-8 [pslug] => 159326-68-8-pyrrolo-2-1-f-1-2-4-triazin-4-amine-bsc-pabsc10818936 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 10818936
Molecular Formula : C6H6N4
Molecular Weight : 134.14
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
